Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Nov 23:22:273.
doi: 10.11604/pamj.2015.22.273.2311. eCollection 2015.

Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C

Mohamed Arrayhani  1 , Tarik Sqalli  1 , Nada Tazi  1 , Randa El Youbi  1 , Safae Chaouch  2 , Nourdin Aqodad  3 , Sidi Adil Ibrahimi  3
Affiliations
Comparative Study

Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C

Mohamed Arrayhani et al. Pan Afr Med J. .

Abstract

The liver biopsy has long been the "gold standard" for assessing liver fibrosis in patients with hepatitis C. It's an invasive procedure which is associated with an elevated bleeding, especially in chronic hemodialysis patients. Main goal is to assess liver fibrosis in chronic hemodialysis with HCV by Fibroscan and by biological scores (APRI, Forns and Fib-4), and to measure the correlation between these tests. Cross-sectional study including all chronic hemodialysis patients with hepatitis C virus, in two public hemodialysis centers of Fez. All patients were evaluated for liver fibrosis using noninvasive methods (FibroScan and laboratory tests). Subsequently, the correlation between different tests has been measured. 95 chronic hemodialysis were studied, twenty nine patients (30.5%) with chronic hepatitis C. The average age was 52.38 ± 16.8 years. Nine liver fibrosis cases have been concluded by forns score. Fibroscan has objectified significant fibrosis in 6 cases. On the other side APRI has objectified sgnifivant fibrosis only in 3 cases. The Fib-4 showed severe fibrosis in five cases. The results have been most consistent between APRI and Fib-4, followed by Fibroscan and Forns, then APRI and FibroScan.

Keywords: APRI; chronic hemodialysis; fib4; fibroscan; forns; hepatitis C virus; liver fibrosis.

PubMed Disclaimer

References

    1. Consolo F, Freni MA. Nosography and immunopathogenesis of viral hepatitis. Nephron. 1992;61(3):251–4. - PubMed
    1. Nousbaum JB, Cadranel JF, Bonnemaison G, Bourlière M, Chiche L, Chor H, et al. Recommandation pour la pratique clinique pour la réalisation de PBH. Gastroenterol Clin Biol. 2002;26(10):848–878. - PubMed
    1. Imbert-Bismuth F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poinard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001 Apr 7;357(9262):1069–75. - PubMed
    1. Poynard T, Imbert-Bismuth F, Munteanu M, Messous D, Myers RP, Thabut D, et al. Overview of the diagnostic value of biochemeical markers of fibrosis (Fibrotest, HCV Fibrosure) and necrosis (Actitest) in patients with chronic hepatitis C. Comparative Hepatology. 2004;3(1):8. - PMC - PubMed
    1. Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42(6):1373–81. - PubMed